Nevertheless, a strict anti-VEGF treatment, possibly including a treat-and-extend strategy [41, 50], has the potential to significantly increase the medical and mental condition of patients, to reduce anxiety, prevent depression development and to support therapeutic compliance. The gene discussed is VEGFA; the disease is depressive symptom measurement.